Table 4. Prevalence of children (aged 10–14 years) with Loa loa microfilariae (overall mf prevalence) and of children within categories of mf intensity the East study sites.

Project	Indicators	Non-CDTI district (%)	CDTI district, 10 yr MDA (%)
East	Mf prevalence	5.3 (95% CI = 7.6–9.5%)	3.4 (95% CI = 1.7–6.2%)
	[1–8,000]mf/ml	3.7 (95% CI = 1.5–7.4%)	3.4 (95% CI = 1.7–6.2%)
	8,001–30,000mf/ml *	1.1 (95% CI = 0.1–3.8)	0.0 (95% CI = 0)
	> 30,000mf/ml**	0.5 (95% CI = 0–2.9%)	0.0 (95% CI = 0)

*Prevalence of individuals at risk of non-neurological complications post ivermectin treatment (see comments above)

**Prevalence of individuals at risk of neurological complications post ivermectin treatment